Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ACELYRIN, INC. - Common Stock
(NQ:
SLRN
)
2.270
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ACELYRIN, INC. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
↗
August 31, 2023
Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) with a Buy rating and
Via
Benzinga
ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
↗
August 15, 2023
One key metric to look for in a stock is an 80-plus Relative Strength Rating. ACELYRIN stock hit that mark on Tuesday, with a jump to 81.
Via
Investor's Business Daily
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
↗
August 15, 2023
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Acelyrin (SLRN) Q2 2023 Earnings Call Transcript
↗
August 14, 2023
SLRN earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Topics
Earnings
ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights
August 14, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
The Week In Charts - More 0DTE. Plus How To Enter A Stock
↗
May 14, 2023
Give an IPO five days to see how the charts settle before jumping in.
Via
Talk Markets
Earnings Scheduled For August 14, 2023
↗
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
ACELYRIN, INC. to Present Second Quarter 2023 Financial Results and Corporate Update on August 14, 2023
August 07, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer
July 18, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
3 Must-Watch Stocks as IPO Valuations Skyrocket
↗
June 28, 2023
The IPO market has come back to life, leading to outsized investor interest in these must-watch stocks in recent weeks.
Via
InvestorPlace
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
↗
June 26, 2023
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
US Stocks Edge Higher; Goldman Sachs Downgrades Tesla To Neutral
↗
June 26, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 25 points on Monday. Following the market opening Monday, the Dow traded up 0.08% to 33,753.64 while the NASDAQ rose...
Via
Benzinga
ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
June 15, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 26, 2023
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
June 07, 2023
On Wednesday, 29 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
May 31, 2023
During Wednesday's session, 212 companies made new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
↗
May 30, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
May 12, 2023
On Friday, 199 companies reached new 52-week lows.
Via
Benzinga
J&J's Kenvue Jumps 20% In Market Debut
↗
May 07, 2023
Shares of Johnson & Johnson's consumer-health spin-off Kenvue soared 20% in their market debut on Thursday, making it the biggest U.S. IPO in over a year. Under Kenvue's umbrella are widely-known...
Via
Talk Markets
Acelyrin Raises $540M In IPO, Stock Gains Over 20% In Trading Debut
↗
May 05, 2023
Acelyrin Inc (NASDAQ: SLRN), a late-stage clinical biopharma company, started trading today and opened at $23/share compared to IPO
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit